Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities. Our technologies and pipeline include proprietary A-Kine™ biologics and Allo-Glue™ small molecule platforms with broad, innovative applications to the reprogramming of disease states. The company is currently advancing multiple novel immunotherapies for the treatment of cancer.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $55M
Investors 5
| Date | Name | Website |
| - | V-Bio Vent... | v-bio.vent... |
| - | Excel Vent... | excelvm.co... |
| - | Wessel Man... | wesselmana... |
| - | Empire Ang... | empireange... |
| - | Solasta Ve... | solasta-ve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.10.2022 | - | $55M | - |
Mentions in press and media 4
| Date | Title | Description |
| 19.10.2022 | Biotech Startup Orionis Gets $55 Million for Cancer Trials | Orionis Biosciences LLC, one of several companies seeking to extend cancer immunotherapy to more patients, has raised $55 million in new venture capital to launch its initial clinical trials. Cancers can suppress the immune system, so start... |
| 19.10.2022 | Orionis Biosciences Secures $55M Financing Round | Orionis Biosciences, a Waltham, MA- and Gent, Belgium-based life sciences company, raised $55M in funding. The round was led by Cormorant Asset Management, and Novartis. Robert Petit joined as Head of Early Clinical Development; Bihua Chen ... |
| - | MD Anderson’s Therapeutics Discovery Division, Orionis Biosciences Launch Project Helios to Advance Novel Small-Molecule Cancer Medicines | BOSTON & GHENT, Belgium & HOUSTON--(BUSINESS WIRE)--Mar 9, 2021-- Orionis Biosciences, a life sciences company pioneering innovation in genome-scale drug discovery, and The University of Texas MD Anderson Cancer Center’s Therapeutic... |
| - | Orionis Biosciences | - |